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tory bowel disease. Importantly, IgG4 serum levels are 
typically not elevated and other organ involvement does 
not occur in AIP type 2  [5] . Therefore, histologic proof of 
 ‘idiopathic duct centric pancreatitis’ with granulocyte ep-
ithelial lesions is required to definitely make the diagnosis 
of AIP type 2  [2] .
 In 2011, the International Consensus Diagnostic Cri-
teria (ICDC) for AIP was published as an attempt to in-
corporate the various existing diagnostic guidelines from 
around the world. Briefly, the ICDC employs 5 key fea-
tures for the diagnosis of AIP: pancreatic imaging, serol-
ogy, other organ involvement, histology and steroid re-
sponsiveness that are graded in level 1 and 2 evidence.
 In this issue of Digestion, Dr. Manser et al.  [6] care-
fully analyzed the diagnostic workup in 29 Swiss patients 
with AIP, which had been prospectively collected since 
2006. Using ICDC, the authors show that more than one-
third of endoscopic retrograde cholangiopancreaticogra-
phies (ERCPs) and endoscopic ultrasounds (EUSs) could 
have been avoided if the diagnostic algorithm suggested 
by the ICDC had been followed. EUS or ERCP was 
deemed unnecessary if the diagnosis of AIP could have 
been established by imaging, histology or IgG4 serum lev-
els, or if a cancer workup had not been indicated/result-
ed  negative. Furthermore, 8 patients were referred for 
 unnecessary pancreatic surgery from other hospitals. 
 The diagnostic and therapeutic management of auto-
immune pancreatitis (AIP) has recently received increas-
ing scientific and clinical attention in the gastroenterol-
ogy community. AIP is a rare pancreatic disorder that 
poses great diagnostic challenges since clinical presenta-
tion can hardly be distinguished from other more fre-
quent forms of pancreatitis or pancreatic cancer. By in-
ternational consensus, we now distinguish 2 clinical sub-
types of AIP, which despite the common name, in fact are 
2 distinctly different entities  [1–3] . AIP type 1 predomi-
nantly occurs in Asia, is mostly found in elderly men and 
can be diagnosed without the use of histologic sampling 
in about 70% of the cases in experienced centers  [4] . It is 
the pancreatic manifestation of a systemic autoimmune 
disorder termed ‘IgG4-related disease’, with multiorgan 
involvement (kidney, salivary glands, biliary tree, retro-
peritoneum, lymph node and prostate) and the hallmark 
feature of IgG4-positive plasma cell infiltrates and elevat-
ed IgG4 plasma levels in the majority of patients. The his-
tological presentation is described as  lymphoplasmic scle-
rosing pancreatitis , and painless obstructive jaundice is 
the most common clinical symptom. In contrast, AIP 
type 2 is a disease that is limited to the pancreas and usu-
ally presents with characteristic painful pancreatitis epi-
sodes. AIP type 2 is often diagnosed in younger Western 
European patients and can be associated with inflamma-
 Published online: September 16, 2015 
 Albrecht Neesse, MD, PhD 
 Department of Gastroenterology and Gastrointestinal Oncology
University Medical Centre, Georg August University Göttingen 
 Robert-Koch-Strasse 40 ,  DE– 37099  Göttingen (Germany) 
 E-Mail albrecht.neesse   @   med.uni-goettingen.de 
 © 2015 S. Karger AG, Basel
0012–2823/15/0923–0171$39.50/0 
 www.karger.com/dig 
 Beyer/Ellenrieder/Neesse Digestion 2015;92:171–172
DOI: 10.1159/000439249
172
 Despite the relatively small study population, this paper 
is very interesting for the gastroenterology community as 
it addresses several issues that clinicians may encounter 
during clinical decision making.
 First, jaundice was the single risk factor associated 
with unnecessary procedures. Although endoscopic or 
surgical interventions are often indicated in patients with 
obstructive jaundice, it is mostly not required in AIP pa-
tients. The fact that the latest estimations have shown that 
the incidence of AIP is about 10 times lower than that of 
pancreatic cancer makes this a particularly challenging 
call  [7] . Therefore, rigorous use of the ICDC will help to 
reduce misdiagnosis and endoscopic or surgical ‘over’-
treatment of AIP. However, if ERCP is still performed due 
to diagnostic uncertainty, the endoscopist should be 
aware of the 4 pancreatographic features that – isolated 
or combined – are highly suggestive for AIP, namely (i) 
long (>1/3 the length of the pancreatic duct) strictures 
with a (ii) lack of upstream dilatation (<5 mm) or (iii) 
multiple strictures  [8] . Unfortunately, the Swiss data col-
lection did not analyze these features in detail.
 From an epidemiological point of view, the study by 
Manser et al.  [6] reveals an unusually high percentage 
of  AIP type 1 that one would not expect in a Western 
 European patient population. However, histological con-
firmation was not provided in most of the AIP cases 
which might have affected the ultimate classification of 
AIP type 1 or type 2.
 Notably, typical imaging findings (sausage-like, dif-
fusely swollen pancreas) that have been described for the 
majority of Asian patients with AIP type 1 were only 
detected in 20% of the Swiss cohort. Although the study 
population was preselected due to a high percentage of 
referred patients from smaller hospitals, the clinical and 
radiographic demonstration of AIP in Western Europe 
might be more heterogeneous and complex than previ-
ously anticipated and may depend on multiple factors, 
for example, time duration after onset of initial symp-
toms. Therefore, histological evidence provided by EUS-
fine needle aspiration (EUS-FNA) provides the most ac-
curate diagnosis and should be strongly advocated if 
AIP cannot be diagnosed by the non-invasive ICDC cri-
teria.
 To conclude, the study by Manser et al.  [6] shows sev-
eral interesting and clinically relevant aspects for the di-
agnostic management of AIP patients. First, the ICDC 
offer a comprehensive strategy for the workup of patients 
with suspected AIP. Rigorous employment of ICDC may 
help to avoid or at least reduce the number of unnecessary 
procedures and surgery. Second, typical imaging findings 
of AIP might be less frequent than initially described in 
the literature, thus further complicating the correct diag-
nosis of AIP. In particular, focal AIP may be an obstacle 
for finding the correct diagnosis by imaging modalities 
and EUS-FNA  [9] . As a consequence, further refinements 
and consequent use of EUS-FNA with subsequent assess-
ment by reference pathologists should be strongly en-
dorsed in cases where suspected AIP cannot be diagnosed 
by non-invasive tests.
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